Federation des caisses Desjardins du Quebec’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-40
Closed -$992 3105
2025
Q4
$992 Buy
+40
New +$1.06K ﹤0.01% 2679

Other funds holding ASTH

Federation des caisses Desjardins du Quebec's ASTH Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec sold out of Astrana Health (ASTH) in Q1 2026, closing a stake of 40 shares — an estimated $992 sold.

Federation des caisses Desjardins du Quebec first reported a position in ASTH in Q4 2025 and held it in 1 quarter. The position peaked at $992 in Q4 2025. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Federation des caisses Desjardins du Quebec reported no remaining Astrana Health position as of Q1 2026 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 40 Astrana Health shares in Q1 2026, an estimated $992.
  • Federation des caisses Desjardins du Quebec first reported a position in Astrana Health in Q4 2025 and held it in 1 quarter.
  • Federation des caisses Desjardins du Quebec's Astrana Health position peaked at $992 in Q4 2025.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.